Bailard »

Actinium Pharmaceuticals shares owned by Bailard

Quarter-by-quarter ownership of Actinium Pharmaceuticals (ATNM) shares owned by Bailard from 13F filings

Historical chart of Bailard investment in Actinium Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Actinium Pharmaceuticals held by Bailard consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actinium Pharmaceuticals by Bailard

Quarter filed Position value Share count Share price at filing
2025-12-31 $79k 58k 1.36

More positions owned by Bailard

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Msci Eafe Etf (EFA)
Gilead Sciences (GILD)
Vanguard World Inf Tech Etf (VGT)
Ishares Tr Calif Mun Bd Etf (CMF)
J P Morgan Exchange Traded F Mortgage Backed (JMTG)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Ibonds 26 Trm Ts (IBTG)

View all positions for Bailard

Top funds holding Actinium Pharmaceuticals

Vanguard Group
Millennium Management
Acadian Asset Management
BlackRock
Geode Capital Management
Renaissance Technologies
Two Sigma Investments
Gagnon Securities
Two Sigma Advisers
Citadel Advisors
State Street Corporation
Susquehanna International
Gen-Wealth Partners
Jane Street
Bailard

View all funds holding Actinium Pharmaceuticals